Department of Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing 100191, China.
J Biol Chem. 2013 Jul 5;288(27):19633-42. doi: 10.1074/jbc.M113.475657. Epub 2013 May 17.
SET8 (SET domain containing 8) is a histone H4 lysine 20 (H4K20)-specific monomethyltransferase in higher eukaryotes that exerts diverse functions in transcription regulation, DNA repair, tumor metastasis, and genome integrity. The activity of SET8 is tightly controlled during cell cycle through post-translational modifications, including ubiquitination, phosphorylation, and sumoylation. However, how the expression of SET8 is regulated is not fully understood. Here, we report that microRNA-7 is a negative regulator of SET8. We demonstrated that microRNA-7 inhibits H4K20 monomethylation and suppresses epithelial-mesenchymal transition and the invasive potential of breast cancer cells. We showed that microRNA-7 promotes spontaneous DNA damages and sensitizes cells to induced DNA damages. Our experiments provide a molecular mechanism for the regulation of SET8 and extend the biological function of microRNA-7 to DNA damage response, supporting the pursuit of microRNA-7 as a potential target for breast cancer intervention.
SET8(SET 结构域包含 8 个)是高等真核生物中组蛋白 H4 赖氨酸 20(H4K20)特异性单甲基转移酶,在转录调控、DNA 修复、肿瘤转移和基因组完整性方面发挥着多种功能。SET8 的活性通过翻译后修饰(包括泛素化、磷酸化和 sumoylation)在细胞周期中受到严格控制。然而,SET8 的表达是如何被调控的还不完全清楚。在这里,我们报告 microRNA-7 是 SET8 的负调控因子。我们证明了 microRNA-7 抑制 H4K20 单甲基化,并抑制乳腺癌细胞的上皮-间充质转化和侵袭潜能。我们表明 microRNA-7 促进自发的 DNA 损伤,并使细胞对诱导的 DNA 损伤敏感。我们的实验为 SET8 的调控提供了一个分子机制,并将 microRNA-7 的生物学功能扩展到 DNA 损伤反应,支持将 microRNA-7 作为乳腺癌干预的潜在靶点进行研究。